Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

  • Roche collaborates with Merck to develop companion diagnostic for use with Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in advanced solid tumors with mismatch repair deficiency (dMMR)
  • Roche will seek FDA approval for biomarker panel expected to provide a standardized predictive testing option for dMMR

Continue reading

Arizona Bioindustry Association receives grant from the U.S. Economic Development Administration to Support Building an Evergreen Seed Fund for Arizona-based Health Innovations

CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that it has been awarded a $299,750 grant  from the U.S. Economic Development Administration’s (EDA) 2018 Regional Innovation Strategies (RIS) program competition to support the creation of a sustainable seed fund for life science innovation in Arizona.  In addition to the federal contribution to the project, AZBio and its partners will provide matching support in excess of $500,000 over the three-year term of the project.  These resources support the seed fund capital campaign, structure and operations as well as programs designed to help Arizona life science companies prepare for the investment process.  Neither the federal funds or the matching funds may be used to capitalize the fund itself or for direct investment into individual companies.Continue reading

HonorHealth to Advance Heart and Vascular Services With Funding From The Bob & Renee Parsons Foundation

The Bob & Renee Parsons Foundation has issued a $500,000 matching grant to aid HonorHealth in its expansion of the heart and vascular services offered at the HonorHealth Shea Medical Center. The new Bob & Renee Parsons Coronary and Structural Heart Lab will provide patients with access to innovative procedures and the most advanced technology available.Continue reading